OMEROS CORP (OMER) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6821431029
OMEROS CORP financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -122.80 m USD |
| EBIT | -4.60 m USD |
| Net income | -3.35 m USD |
| Diluted EPS – continuing operations | -0.05 USD |
Full history since 2005, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About OMEROS CORP
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
More stocks
- RPC INC (RES)
- Vitec Software Group AB (publ) (VIT B.ST)
- Nuvoton Technology Corp (4919.TW)
- UroGen Pharma Ltd. (URGN)
- TR Property Investment Trust PLC (TRY.L)
- Aurora Optoelectronics Co Ltd (600666.SS)
- ARTIVION, INC. (AORT)
- HANA Micron Inc (067310.KQ)
- Shanghai Fengyuzhu Exhibition Co Ltd Class A (603466.SS)
- NEKTAR THERAPEUTICS (NKTR)
- TUHU Car Inc (9690.HK)
- InnovAge Holding Corp. (INNV)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.